Welcure Drugs & Pharmaceuticals Ltd. | Small-cap | Healthcare
₹12.96
4.94%
| Welcure Drugs Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 245.5M
Gross Profit 40.5M 16.48%
Operating Income 8.7M 3.54%
Net Income 21.7M 8.84%

Balance Sheet Metrics

Total Assets 2.7B
Total Liabilities 1.6B
Shareholders Equity 1.0B
Debt to Equity 1.60

Cash Flow Metrics

Operating Cash Flow -2.2B
Free Cash Flow -2.2B

Revenue & Profitability Trend

Welcure Drugs Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue245.5M001.0M1.3M
Cost of Goods Sold205.0M0000
Gross Profit40.5M0000
Operating Expenses28.9M1.1M899.0K661.1K679.8K
Operating Income8.7M-2.7M-1.4M236.5K550.2K
Pre-tax Income27.8M-1.7M1.0M235.8K551.5K
Income Tax6.1M0000
Net Income21.7M-1.7M1.0M235.8K551.5K
EPS (Diluted)--₹0.13₹0.08₹0.02₹0.05

Income Statement Trend

Welcure Drugs Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets1.8B318.0K59.0K660.1K474.6K
Non-Current Assets848.4M13.4M15.2M308.1K255.6K
Total Assets2.7B13.7M15.3M968.2K730.2K
Liabilities
Current Liabilities412.7M306.0K136.0K38.2K35.9K
Non-Current Liabilities1.2B0000
Total Liabilities1.6B306.0K136.0K38.2K35.9K
Equity
Total Shareholders Equity1.0B13.4M15.2M930.0K694.2K

Balance Sheet Composition

Welcure Drugs Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income27.8M-1.7M1.0M235.8K551.5K
Operating Cash Flow-2.2B-1.6M1.1M185.5K421.9K
Investing Activities
Capital Expenditures-170.0K----
Investing Cash Flow-635.0K1.6M0--
Financing Activities
Dividends Paid-----
Financing Cash Flow2.2B-171.0K-1.7M--
Free Cash Flow-2.2B-1.3M1.1M185.5K421.9K

Cash Flow Trend

Welcure Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 39.86
Price to Book 1.08
Price to Sales 6.58

Profitability Ratios

Profit Margin 8.84%
Operating Margin 2.97%
Return on Equity 4.18%
Return on Assets 1.29%

Financial Health

Current Ratio 4.41
Debt to Equity 120.18
Beta -1.28

Per Share Data

EPS (TTM) ₹0.36
Book Value per Share ₹13.32
Revenue per Share ₹4.07

Financial data is updated regularly. All figures are in the company's reporting currency.